Kobe Pharmaceutical University
In research, Kobe Pharmaceutical University stands highest in Life Sciences (#5,694 of 7,800 worldwide), 2022–2025.
- World rank, 2022–2025
- #12,791 of 28,054 · #10,188 all time
- Rank in Japan
- #333 of 1,070
- Research works
- 2k ▼ 22% vs 2013–17
- Citations
- 41k 20.6 per fractional work
- Top-10% rate
- 8.4% record average 16.5%
- Open access
- 43% world 28%
What is Kobe Pharmaceutical University known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #5,694 of 7,800 | 7.3% | 81 | #6202 |
Each strip is that field’s whole ranked pool, with the notch where Kobe Pharmaceutical University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.8×
- Chemistry 7.7×
- Biochemistry, Genetics and Molecular Biology 5.0×
- Immunology and Microbiology 4.5×
- Neuroscience 4.1×
- Nursing 3.1×
- Materials Science 1.6×
- Medicine 1.4×
- Veterinary 0.7×
- Environmental Science 0.5×
- Chemical Engineering 0.5×
- Earth and Planetary Sciences 0.5×
- Agricultural and Biological Sciences 0.4×
- Energy 0.4×
- Health Professions 0.3×
- Mathematics 0.2×
- Engineering 0.2×
- Physics and Astronomy 0.2×
- Dentistry 0.2×
- Arts and Humanities 0.2×
- Psychology 0.1×
- Business, Management and Accounting 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Decision Sciences 0.0×
- Social Sciences 0.0×
Who are the top researchers at Kobe Pharmaceutical University?
Ranked on the composite score, Kazuyuki Sugahara, Kinuko Iwasa and Masataka Moriyasu lead among researchers whose main affiliation is Kobe Pharmaceutical University.
- 1 Kazuyuki Sugahara Japan · #52,822 worldwide 396 citations · 56 works
- 2 Kinuko Iwasa Japan · #168,988 worldwide 110 citations · 27 works
- 3 Masataka Moriyasu Japan · #170,347 worldwide 127 citations · 28 works
- 4 Hiroshi Kitagawa Japan · #274,404 worldwide 347 citations · 97 works
- 5 ISAO SUGIMOTO Japan · #370,191 worldwide 66 citations · 23 works
- 6 Naoko Tsugawa Japan · #377,962 worldwide 61 citations · 19 works
- 7 Hiroaki Nanba Japan · #409,937 worldwide 76 citations · 17 works
- 8 Takao Tanahashi Japan · #416,293 worldwide 95 citations · 27 works
- 9 Takeaki Naito Japan · #457,572 worldwide 287 citations · 91 works
- 10 Keiko Yagi Japan · #486,839 worldwide 92 citations · 19 works
Which keywords describe research at Kobe Pharmaceutical University?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Oxidative Stress, Cancer, Nanoparticles, Drug Delivery, Angiogenesis, Cancer Therapy and Cell Signaling.
- Gene Therapy
- Treatment Guidelines
- Therapeutic Antibodies
- Atherosclerosis
- Microglia
- Pulmonary Hypertension
- Neurodegeneration
- Innate Immunity
- Proteoglycans
- Enantioselective Synthesis
- Toll-like Receptors
- Surface Engineering
- Endothelial Dysfunction
- Neuroinflammation
- Reactive Oxygen Species
- Tumor Targeting
- Biomedical Applications
- Angiogenesis
- Nanoparticles
- Oxidative Stress
- Inflammation
- Cancer
- Drug Delivery
- Cancer Therapy
- Cell Signaling
- Transition Metal Catalysis
- Cytokines
- Synaptic Plasticity
- Nanocarriers
- Glycosylation
- Heterocycles
- Hyaluronan
- Immune System
- Metal-Catalyzed Reactions
- Metabolism
- Echocardiography
- Monoclonal Antibodies
- Chronic Kidney Disease
- Right Heart Assessment
- Drug Discovery
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation22▲ 5.6×44 topics
- Oxidative Stress17▲ 5.4×38 topics
- Cancer14▲ 5.3×29 topics
- Nanoparticles12▲ 4.9×11 topics
- Drug Delivery9▲ 8.9×7 topics
- Angiogenesis9▲ 14×8 topics
- Cancer Therapy8▲ 7.5×10 topics
- Biomedical Applications8▲ 3.5×11 topics
- Cell Signaling8▲ 26×8 topics
- Tumor Targeting7▲ 22×3 topics
- Transition Metal Catalysis7▲ 43×4 topics
- Reactive Oxygen Species6▲ 8.4×9 topics
- Cytokines6▲ 12×6 topics
- Neuroinflammation6▲ 11×6 topics
- Synaptic Plasticity6▲ 14×3 topics
- Endothelial Dysfunction6▲ 13×4 topics
- Nanocarriers6▲ 53×1 topic
- Surface Engineering6▲ 32×1 topic
- Glycosylation5▲ 25×3 topics
- Toll-like Receptors5▲ 25×3 topics
- Heterocycles5▲ 30×3 topics
- Enantioselective Synthesis5▲ 40×5 topics
- Hyaluronan5▲ 184×1 topic
- Proteoglycans5▲ 184×1 topic
- Immune System5▲ 10×6 topics
- Innate Immunity5▲ 7.7×6 topics
- Metal-Catalyzed Reactions5▲ 40×3 topics
- Neurodegeneration5▲ 8.1×6 topics
- Metabolism4▲ 4.7×13 topics
- Pulmonary Hypertension4▲ 16×2 topics
- Echocardiography4▲ 8.3×3 topics
- Microglia4▲ 19×2 topics
- Monoclonal Antibodies4▲ 23×3 topics
- Atherosclerosis4▲ 7.1×7 topics
- Chronic Kidney Disease4▲ 8.3×2 topics
- Therapeutic Antibodies4▲ 29×2 topics
- Right Heart Assessment4▲ 48×1 topic
- Treatment Guidelines4▲ 9.0×1 topic
- Drug Discovery4▲ 8.5×7 topics
- Gene Therapy4▲ 10×5 topics
Which research topics does Kobe Pharmaceutical University publish most on?
By volume in 2022–2025: Nanoparticle-Based Drug Delivery, Proteoglycans and glycosaminoglycans research, Pulmonary Hypertension Research and Treatments and Catalytic C–H Functionalization Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Nanoparticle-Based Drug Delivery Biomaterials 6 works
- 2 Proteoglycans and glycosaminoglycans research Cell Biology 5 works
- 3 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 4 works
- 4 Catalytic C–H Functionalization Methods Organic Chemistry 3 works
- 5 Neuroinflammation and Neurodegeneration Mechanisms Neurology 3 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 7 RNA Interference and Gene Delivery Molecular Biology 2 works
- 8 Genomics, phytochemicals, and oxidative stress Molecular Biology 2 works
- 9 Glycosylation and Glycoproteins Research Molecular Biology 2 works
- 10 Chemical Synthesis and Analysis Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Kobe Pharmaceutical University's research output changed?
Output in 2018–2022 was 22% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kobe
- Kobe University
- University of Hyogo
- Konan University
- Kobe Steel (Japan)
- Kobe City Medical Center General Hospital
- Kobe Gakuin University
- RIKEN Advanced Science Institute
- RIKEN Center for Computational Science
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.